ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Reduced Glutathione (GSH) Drugs Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-33C7652
Home | Market Reports | Science| Biological Sciences
Global Reduced Glutathione GSH Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Reduced Glutathione (GSH) Drugs Market Research Report 2025

Code: QYRE-Auto-33C7652
Report
July 2025
Pages:72
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Chongqing Yaoyou
Shanghai Fudan Fuhua Pharmaceutical
Italy Sid Pharmaceutical Factory
Kunming Jida
Lvye Pharma

Reduced Glutathione (GSH) Drugs Market

The global market for Reduced Glutathione (GSH) Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Reduced glutathione is a peptide naturally synthesized in human cytoplasm, composed of glutamic acid, cysteine and glycine.
North American market for Reduced Glutathione (GSH) Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Reduced Glutathione (GSH) Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Reduced Glutathione (GSH) Drugs include Chongqing Yaoyou, Shanghai Fudan Fuhua Pharmaceutical, Italy Sid Pharmaceutical Factory, Kunming Jida, Lvye Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Reduced Glutathione (GSH) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Reduced Glutathione (GSH) Drugs.
The Reduced Glutathione (GSH) Drugs market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Reduced Glutathione (GSH) Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Reduced Glutathione (GSH) Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Reduced Glutathione (GSH) Drugs Market Report

Report Metric Details
Report Name Reduced Glutathione (GSH) Drugs Market
Segment by Type
  • Tablet
  • Injection
  • Other
Segment by Application
  • Anemia
  • Asthma
  • Cataract
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Chongqing Yaoyou, Shanghai Fudan Fuhua Pharmaceutical, Italy Sid Pharmaceutical Factory, Kunming Jida, Lvye Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Reduced Glutathione (GSH) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Reduced Glutathione (GSH) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Reduced Glutathione (GSH) Drugs Market report?

Ans: The main players in the Reduced Glutathione (GSH) Drugs Market are Chongqing Yaoyou, Shanghai Fudan Fuhua Pharmaceutical, Italy Sid Pharmaceutical Factory, Kunming Jida, Lvye Pharma

What are the Application segmentation covered in the Reduced Glutathione (GSH) Drugs Market report?

Ans: The Applications covered in the Reduced Glutathione (GSH) Drugs Market report are Anemia, Asthma, Cataract, Other

What are the Type segmentation covered in the Reduced Glutathione (GSH) Drugs Market report?

Ans: The Types covered in the Reduced Glutathione (GSH) Drugs Market report are Tablet, Injection, Other

1 Reduced Glutathione (GSH) Drugs Market Overview
1.1 Product Definition
1.2 Reduced Glutathione (GSH) Drugs by Type
1.2.1 Global Reduced Glutathione (GSH) Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Tablet
1.2.3 Injection
1.2.4 Other
1.3 Reduced Glutathione (GSH) Drugs by Application
1.3.1 Global Reduced Glutathione (GSH) Drugs Market Value by Application (2024 VS 2031)
1.3.2 Anemia
1.3.3 Asthma
1.3.4 Cataract
1.3.5 Other
1.4 Global Reduced Glutathione (GSH) Drugs Market Size Estimates and Forecasts
1.4.1 Global Reduced Glutathione (GSH) Drugs Revenue 2020-2031
1.4.2 Global Reduced Glutathione (GSH) Drugs Sales 2020-2031
1.4.3 Global Reduced Glutathione (GSH) Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Reduced Glutathione (GSH) Drugs Market Competition by Manufacturers
2.1 Global Reduced Glutathione (GSH) Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Reduced Glutathione (GSH) Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Reduced Glutathione (GSH) Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Reduced Glutathione (GSH) Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Reduced Glutathione (GSH) Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Reduced Glutathione (GSH) Drugs, Product Type & Application
2.7 Global Key Manufacturers of Reduced Glutathione (GSH) Drugs, Date of Enter into This Industry
2.8 Global Reduced Glutathione (GSH) Drugs Market Competitive Situation and Trends
2.8.1 Global Reduced Glutathione (GSH) Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Reduced Glutathione (GSH) Drugs Players Market Share by Revenue
2.8.3 Global Reduced Glutathione (GSH) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Reduced Glutathione (GSH) Drugs Market Scenario by Region
3.1 Global Reduced Glutathione (GSH) Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Reduced Glutathione (GSH) Drugs Sales by Region: 2020-2031
3.2.1 Global Reduced Glutathione (GSH) Drugs Sales by Region: 2020-2025
3.2.2 Global Reduced Glutathione (GSH) Drugs Sales by Region: 2026-2031
3.3 Global Reduced Glutathione (GSH) Drugs Revenue by Region: 2020-2031
3.3.1 Global Reduced Glutathione (GSH) Drugs Revenue by Region: 2020-2025
3.3.2 Global Reduced Glutathione (GSH) Drugs Revenue by Region: 2026-2031
3.4 North America Reduced Glutathione (GSH) Drugs Market Facts & Figures by Country
3.4.1 North America Reduced Glutathione (GSH) Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Reduced Glutathione (GSH) Drugs Sales by Country (2020-2031)
3.4.3 North America Reduced Glutathione (GSH) Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Reduced Glutathione (GSH) Drugs Market Facts & Figures by Country
3.5.1 Europe Reduced Glutathione (GSH) Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Reduced Glutathione (GSH) Drugs Sales by Country (2020-2031)
3.5.3 Europe Reduced Glutathione (GSH) Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Reduced Glutathione (GSH) Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Reduced Glutathione (GSH) Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Reduced Glutathione (GSH) Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Reduced Glutathione (GSH) Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Reduced Glutathione (GSH) Drugs Market Facts & Figures by Country
3.7.1 Latin America Reduced Glutathione (GSH) Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Reduced Glutathione (GSH) Drugs Sales by Country (2020-2031)
3.7.3 Latin America Reduced Glutathione (GSH) Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Reduced Glutathione (GSH) Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Reduced Glutathione (GSH) Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Reduced Glutathione (GSH) Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Reduced Glutathione (GSH) Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Reduced Glutathione (GSH) Drugs Sales by Type (2020-2031)
4.1.1 Global Reduced Glutathione (GSH) Drugs Sales by Type (2020-2025)
4.1.2 Global Reduced Glutathione (GSH) Drugs Sales by Type (2026-2031)
4.1.3 Global Reduced Glutathione (GSH) Drugs Sales Market Share by Type (2020-2031)
4.2 Global Reduced Glutathione (GSH) Drugs Revenue by Type (2020-2031)
4.2.1 Global Reduced Glutathione (GSH) Drugs Revenue by Type (2020-2025)
4.2.2 Global Reduced Glutathione (GSH) Drugs Revenue by Type (2026-2031)
4.2.3 Global Reduced Glutathione (GSH) Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Reduced Glutathione (GSH) Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Reduced Glutathione (GSH) Drugs Sales by Application (2020-2031)
5.1.1 Global Reduced Glutathione (GSH) Drugs Sales by Application (2020-2025)
5.1.2 Global Reduced Glutathione (GSH) Drugs Sales by Application (2026-2031)
5.1.3 Global Reduced Glutathione (GSH) Drugs Sales Market Share by Application (2020-2031)
5.2 Global Reduced Glutathione (GSH) Drugs Revenue by Application (2020-2031)
5.2.1 Global Reduced Glutathione (GSH) Drugs Revenue by Application (2020-2025)
5.2.2 Global Reduced Glutathione (GSH) Drugs Revenue by Application (2026-2031)
5.2.3 Global Reduced Glutathione (GSH) Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Reduced Glutathione (GSH) Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Chongqing Yaoyou
6.1.1 Chongqing Yaoyou Company Information
6.1.2 Chongqing Yaoyou Description and Business Overview
6.1.3 Chongqing Yaoyou Reduced Glutathione (GSH) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Chongqing Yaoyou Reduced Glutathione (GSH) Drugs Product Portfolio
6.1.5 Chongqing Yaoyou Recent Developments/Updates
6.2 Shanghai Fudan Fuhua Pharmaceutical
6.2.1 Shanghai Fudan Fuhua Pharmaceutical Company Information
6.2.2 Shanghai Fudan Fuhua Pharmaceutical Description and Business Overview
6.2.3 Shanghai Fudan Fuhua Pharmaceutical Reduced Glutathione (GSH) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Shanghai Fudan Fuhua Pharmaceutical Reduced Glutathione (GSH) Drugs Product Portfolio
6.2.5 Shanghai Fudan Fuhua Pharmaceutical Recent Developments/Updates
6.3 Italy Sid Pharmaceutical Factory
6.3.1 Italy Sid Pharmaceutical Factory Company Information
6.3.2 Italy Sid Pharmaceutical Factory Description and Business Overview
6.3.3 Italy Sid Pharmaceutical Factory Reduced Glutathione (GSH) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Italy Sid Pharmaceutical Factory Reduced Glutathione (GSH) Drugs Product Portfolio
6.3.5 Italy Sid Pharmaceutical Factory Recent Developments/Updates
6.4 Kunming Jida
6.4.1 Kunming Jida Company Information
6.4.2 Kunming Jida Description and Business Overview
6.4.3 Kunming Jida Reduced Glutathione (GSH) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Kunming Jida Reduced Glutathione (GSH) Drugs Product Portfolio
6.4.5 Kunming Jida Recent Developments/Updates
6.5 Lvye Pharma
6.5.1 Lvye Pharma Company Information
6.5.2 Lvye Pharma Description and Business Overview
6.5.3 Lvye Pharma Reduced Glutathione (GSH) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Lvye Pharma Reduced Glutathione (GSH) Drugs Product Portfolio
6.5.5 Lvye Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Reduced Glutathione (GSH) Drugs Industry Chain Analysis
7.2 Reduced Glutathione (GSH) Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Reduced Glutathione (GSH) Drugs Production Mode & Process Analysis
7.4 Reduced Glutathione (GSH) Drugs Sales and Marketing
7.4.1 Reduced Glutathione (GSH) Drugs Sales Channels
7.4.2 Reduced Glutathione (GSH) Drugs Distributors
7.5 Reduced Glutathione (GSH) Drugs Customer Analysis
8 Reduced Glutathione (GSH) Drugs Market Dynamics
8.1 Reduced Glutathione (GSH) Drugs Industry Trends
8.2 Reduced Glutathione (GSH) Drugs Market Drivers
8.3 Reduced Glutathione (GSH) Drugs Market Challenges
8.4 Reduced Glutathione (GSH) Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Chongqing Yaoyou
Shanghai Fudan Fuhua Pharmaceutical
Italy Sid Pharmaceutical Factory
Kunming Jida
Lvye Pharma
List of Tables
 Table 1. Global Reduced Glutathione (GSH) Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Reduced Glutathione (GSH) Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Reduced Glutathione (GSH) Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Reduced Glutathione (GSH) Drugs Sales (KG) of Key Manufacturers (2020-2025)
 Table 5. Global Reduced Glutathione (GSH) Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Reduced Glutathione (GSH) Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Reduced Glutathione (GSH) Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Reduced Glutathione (GSH) Drugs Average Price (US$/G) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Reduced Glutathione (GSH) Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Reduced Glutathione (GSH) Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Reduced Glutathione (GSH) Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Reduced Glutathione (GSH) Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Reduced Glutathione (GSH) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Reduced Glutathione (GSH) Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Reduced Glutathione (GSH) Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Reduced Glutathione (GSH) Drugs Sales by Region (2020-2025) & (KG)
 Table 18. Global Reduced Glutathione (GSH) Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Reduced Glutathione (GSH) Drugs Sales by Region (2026-2031) & (KG)
 Table 20. Global Reduced Glutathione (GSH) Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Reduced Glutathione (GSH) Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Reduced Glutathione (GSH) Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Reduced Glutathione (GSH) Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Reduced Glutathione (GSH) Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Reduced Glutathione (GSH) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Reduced Glutathione (GSH) Drugs Sales by Country (2020-2025) & (KG)
 Table 27. North America Reduced Glutathione (GSH) Drugs Sales by Country (2026-2031) & (KG)
 Table 28. North America Reduced Glutathione (GSH) Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Reduced Glutathione (GSH) Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Reduced Glutathione (GSH) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Reduced Glutathione (GSH) Drugs Sales by Country (2020-2025) & (KG)
 Table 32. Europe Reduced Glutathione (GSH) Drugs Sales by Country (2026-2031) & (KG)
 Table 33. Europe Reduced Glutathione (GSH) Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Reduced Glutathione (GSH) Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Reduced Glutathione (GSH) Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Reduced Glutathione (GSH) Drugs Sales by Region (2020-2025) & (KG)
 Table 37. Asia Pacific Reduced Glutathione (GSH) Drugs Sales by Region (2026-2031) & (KG)
 Table 38. Asia Pacific Reduced Glutathione (GSH) Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Reduced Glutathione (GSH) Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Reduced Glutathione (GSH) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Reduced Glutathione (GSH) Drugs Sales by Country (2020-2025) & (KG)
 Table 42. Latin America Reduced Glutathione (GSH) Drugs Sales by Country (2026-2031) & (KG)
 Table 43. Latin America Reduced Glutathione (GSH) Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Reduced Glutathione (GSH) Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Reduced Glutathione (GSH) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Reduced Glutathione (GSH) Drugs Sales by Country (2020-2025) & (KG)
 Table 47. Middle East and Africa Reduced Glutathione (GSH) Drugs Sales by Country (2026-2031) & (KG)
 Table 48. Middle East and Africa Reduced Glutathione (GSH) Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Reduced Glutathione (GSH) Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Reduced Glutathione (GSH) Drugs Sales (KG) by Type (2020-2025)
 Table 51. Global Reduced Glutathione (GSH) Drugs Sales (KG) by Type (2026-2031)
 Table 52. Global Reduced Glutathione (GSH) Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Reduced Glutathione (GSH) Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Reduced Glutathione (GSH) Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Reduced Glutathione (GSH) Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Reduced Glutathione (GSH) Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Reduced Glutathione (GSH) Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Reduced Glutathione (GSH) Drugs Price (US$/G) by Type (2020-2025)
 Table 59. Global Reduced Glutathione (GSH) Drugs Price (US$/G) by Type (2026-2031)
 Table 60. Global Reduced Glutathione (GSH) Drugs Sales (KG) by Application (2020-2025)
 Table 61. Global Reduced Glutathione (GSH) Drugs Sales (KG) by Application (2026-2031)
 Table 62. Global Reduced Glutathione (GSH) Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Reduced Glutathione (GSH) Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Reduced Glutathione (GSH) Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Reduced Glutathione (GSH) Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Reduced Glutathione (GSH) Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Reduced Glutathione (GSH) Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Reduced Glutathione (GSH) Drugs Price (US$/G) by Application (2020-2025)
 Table 69. Global Reduced Glutathione (GSH) Drugs Price (US$/G) by Application (2026-2031)
 Table 70. Chongqing Yaoyou Company Information
 Table 71. Chongqing Yaoyou Description and Business Overview
 Table 72. Chongqing Yaoyou Reduced Glutathione (GSH) Drugs Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 73. Chongqing Yaoyou Reduced Glutathione (GSH) Drugs Product
 Table 74. Chongqing Yaoyou Recent Developments/Updates
 Table 75. Shanghai Fudan Fuhua Pharmaceutical Company Information
 Table 76. Shanghai Fudan Fuhua Pharmaceutical Description and Business Overview
 Table 77. Shanghai Fudan Fuhua Pharmaceutical Reduced Glutathione (GSH) Drugs Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 78. Shanghai Fudan Fuhua Pharmaceutical Reduced Glutathione (GSH) Drugs Product
 Table 79. Shanghai Fudan Fuhua Pharmaceutical Recent Developments/Updates
 Table 80. Italy Sid Pharmaceutical Factory Company Information
 Table 81. Italy Sid Pharmaceutical Factory Description and Business Overview
 Table 82. Italy Sid Pharmaceutical Factory Reduced Glutathione (GSH) Drugs Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 83. Italy Sid Pharmaceutical Factory Reduced Glutathione (GSH) Drugs Product
 Table 84. Italy Sid Pharmaceutical Factory Recent Developments/Updates
 Table 85. Kunming Jida Company Information
 Table 86. Kunming Jida Description and Business Overview
 Table 87. Kunming Jida Reduced Glutathione (GSH) Drugs Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 88. Kunming Jida Reduced Glutathione (GSH) Drugs Product
 Table 89. Kunming Jida Recent Developments/Updates
 Table 90. Lvye Pharma Company Information
 Table 91. Lvye Pharma Description and Business Overview
 Table 92. Lvye Pharma Reduced Glutathione (GSH) Drugs Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 93. Lvye Pharma Reduced Glutathione (GSH) Drugs Product
 Table 94. Lvye Pharma Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Reduced Glutathione (GSH) Drugs Distributors List
 Table 98. Reduced Glutathione (GSH) Drugs Customers List
 Table 99. Reduced Glutathione (GSH) Drugs Market Trends
 Table 100. Reduced Glutathione (GSH) Drugs Market Drivers
 Table 101. Reduced Glutathione (GSH) Drugs Market Challenges
 Table 102. Reduced Glutathione (GSH) Drugs Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Reduced Glutathione (GSH) Drugs
 Figure 2. Global Reduced Glutathione (GSH) Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Reduced Glutathione (GSH) Drugs Market Share by Type: 2024 & 2031
 Figure 4. Tablet Product Picture
 Figure 5. Injection Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Reduced Glutathione (GSH) Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Reduced Glutathione (GSH) Drugs Market Share by Application: 2024 & 2031
 Figure 9. Anemia
 Figure 10. Asthma
 Figure 11. Cataract
 Figure 12. Other
 Figure 13. Global Reduced Glutathione (GSH) Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Reduced Glutathione (GSH) Drugs Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Reduced Glutathione (GSH) Drugs Sales (2020-2031) & (KG)
 Figure 16. Global Reduced Glutathione (GSH) Drugs Average Price (US$/G) & (2020-2031)
 Figure 17. Reduced Glutathione (GSH) Drugs Report Years Considered
 Figure 18. Reduced Glutathione (GSH) Drugs Sales Share by Manufacturers in 2024
 Figure 19. Global Reduced Glutathione (GSH) Drugs Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Reduced Glutathione (GSH) Drugs Players: Market Share by Revenue in Reduced Glutathione (GSH) Drugs in 2024
 Figure 21. Reduced Glutathione (GSH) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Reduced Glutathione (GSH) Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Reduced Glutathione (GSH) Drugs Sales Market Share by Country (2020-2031)
 Figure 24. North America Reduced Glutathione (GSH) Drugs Revenue Market Share by Country (2020-2031)
 Figure 25. United States Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Reduced Glutathione (GSH) Drugs Sales Market Share by Country (2020-2031)
 Figure 28. Europe Reduced Glutathione (GSH) Drugs Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Reduced Glutathione (GSH) Drugs Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Reduced Glutathione (GSH) Drugs Revenue Market Share by Region (2020-2031)
 Figure 36. China Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Reduced Glutathione (GSH) Drugs Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Reduced Glutathione (GSH) Drugs Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Reduced Glutathione (GSH) Drugs Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Reduced Glutathione (GSH) Drugs Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Reduced Glutathione (GSH) Drugs by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Reduced Glutathione (GSH) Drugs by Type (2020-2031)
 Figure 57. Global Reduced Glutathione (GSH) Drugs Price (US$/G) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Reduced Glutathione (GSH) Drugs by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Reduced Glutathione (GSH) Drugs by Application (2020-2031)
 Figure 60. Global Reduced Glutathione (GSH) Drugs Price (US$/G) by Application (2020-2031)
 Figure 61. Reduced Glutathione (GSH) Drugs Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Glutathione for Injection Market Research Report 2024
Global Reduced Glutathione GSH Market Research Report 2025
Global Glutathione Supplement Market Research Report 2024
Global L Glutathione Market Insights Forecast to 2030
Global Pharmaceutical Grade Glutathione Market Research Report 2024
Global L Glutathione Reduced Market Research Report 2024
Food Grade Glutathione Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Reduced L Glutathione Market Research Report 2025
Global Reduced Glutathione for Injection Market Research Report 2024
Global Glutathione Tablet Market Research Report 2024
Global Oral Glutathione Supplements Market Research Report 2024
Global Liposomal Glutathione Market Research Report 2024
Global Glutathione Market Research Report 2025
Global Cosmetic Grade Glutathione Market Research Report 2024
Glutathione Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmaceutical Grade Glutamine Market Research Report 2024
Global GSH GSSG Assay Kit Market Research Report 2025
Global L Cysteine and Its Hydrochloride Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Methionine for Pharmaceutical Market Insights Forecast to 2030
Global Nutraceutical Grade Glutamine Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions